Day: June 26, 2022

Jack Johnson Has Announced A 2022 Australian Tour

Jack Johnson has announced he’ll return to Australian shores later this year, with the singer-songwriter playing five shows across the country in November and December. All gigs will be held outside, taking place at Kings Park in Perth, HOTA Amphitheatre on the Gold Coast, Riverstage in Brisbane, the Sydney Opera House forecourt and Melbourne’s Sidney […]

Earl Sweatshirt, Flight Facilities Lead THIS THAT 2022 Lineup

THIS THAT will take place for a second time in 2022, with organisers announcing the lineup for the festival’s return to Newcastle and Sandstone Point in October and November respectively. On the international front, Earl Sweatshirt and UPSAHL feature on the bill, which otherwise is heavily local. Flight Facilities, Winston Surfshirt, Alice Ivy, Jesswar, Ruby Fields, Dear […]


Acquisition Grows TricorBraun’s Australian Presence, Continues Company’s Global Expansion ST. LOUIS, June 27, 2022 /PRNewswire/ — Global packaging leader TricorBraun announced today that it has successfully completed its acquisition of PB Packaging (“PB”), a leading Australian provider of plastic and glass packaging. The acquisition grows TricorBraun’s presence in Australia and continues the company’s global expansion. […]

“I Want As Many People to See Me Die On Stage As Possible” – A Chaotic Interview with TISM

When cult Australian band TISM announced their reunion earlier this month, expressions such as “long-overdue reformation” and “nostalgic delight” peppered the discourse. However, one word that was missing from the majority of discussions was “chaotic”. Yes, after 18 years, TISM have found their way back into the public consciousness, with a trio of performances lined […]

Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application

SHANGHAI, June 26, 2022 /PRNewswire/ — On June 15, 2022, Dragon Boat announced that its IND application of the innovative anti-CLDN 18.2/CD47 bi-specific antibody (bsAb) injection (R&D code: BC007) was officially accepted by National Medical Products Administration (NMPA) under the acceptance number CXSL2200267. This drug is the first domestic clinical filing of the CLDN 18.2/ […]

Back To Top